Medlive Technology Co., Ltd. (2192.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.42B |
| Enterprise Value | 3.86B |
| P/E Ratio | 12.76 |
| PEG Ratio | 2.74 |
| Price/Sales Ratio | 6.62 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 2.63 |
| Enterprise/EBITDA | 9.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.52 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 642.16M |
| Revenue/Share | 0.88 |
| Gross Profit | 385.44M |
| EBITDA | 174.99M |
| Net Income | 334.34M |
| Diluted EPS | 0.45 |
Balance Sheet
| Total Cash | 3.72B |
| Total Cash/Share | 5.07 |
| Total Debt | 10.11M |
| Total Debt/Equity | 0 |
| Current Ratio | 19.09 |
| Book Value Per Share | 6.72 |
Price History
| 52-Week Change | -56.54 |
| 52-Week High | 16.84 |
| 52-Week Low | 6.51 |
| Moving Average 50 Days | 8.08 |
| Moving Average 200 Days | 9.92 |
Statistics
| Average Volume | 1.72M |
| Shares Outstanding | 739.96M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 4.38 |
| Payout Ratio | 0.56 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
